These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15003298)

  • 21. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report.
    Suzuki S; Sayama T; Nakamura T; Nishimura H; Ohta M; Inoue T; Mannoji H; Takeshita I
    Cerebrovasc Dis; 2011; 32(1):89-93. PubMed ID: 21677432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
    Lynch JR; Wang H; McGirt MJ; Floyd J; Friedman AH; Coon AL; Blessing R; Alexander MJ; Graffagnino C; Warner DS; Laskowitz DT
    Stroke; 2005 Sep; 36(9):2024-6. PubMed ID: 16051891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage.
    Juvela S; Siironen J; Varis J; Poussa K; Porras M
    J Neurosurg; 2005 Feb; 102(2):194-201. PubMed ID: 15739544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus.
    Harrigan MR; Rajneesh KF; Ardelt AA; Fisher WS
    Neurosurgery; 2010 Oct; 67(4):935-9; discussion 939-40. PubMed ID: 20881558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage--results of a multi-center controlled double-blind clinical study].
    Hashi K; Takakura K; Sano K; Ohta T; Saito I; Okada K
    No To Shinkei; 1988 Apr; 40(4):373-82. PubMed ID: 3042005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basilar vasospasm following spontaneous and traumatic subarachnoid haemorrhage: clinical implications.
    Soustiel JF; Shik V; Feinsod M
    Acta Neurochir (Wien); 2002 Feb; 144(2):137-44; discussion 144. PubMed ID: 11862513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
    Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
    Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
    J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
    Veyna RS; Seyfried D; Burke DG; Zimmerman C; Mlynarek M; Nichols V; Marrocco A; Thomas AJ; Mitsias PD; Malik GM
    J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The attenuation of vasospasm by using a sod mimetic after experimental subarachnoidal haemorrhage in rats.
    Aladag MA; Turkoz Y; Sahna E; Parlakpinar H; Gul M
    Acta Neurochir (Wien); 2003 Aug; 145(8):673-7. PubMed ID: 14520547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome.
    Taha MM; Nakahara I; Higashi T; Iwamuro Y; Iwaasa M; Watanabe Y; Tsunetoshi K; Munemitsu T
    Surg Neurol; 2006 Sep; 66(3):277-84; discussion 284. PubMed ID: 16935636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.
    Seule MA; Muroi C; Mink S; Yonekawa Y; Keller E
    Neurosurgery; 2009 Jan; 64(1):86-92; discussion 92-3. PubMed ID: 19050656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH.
    Hendryk S; Jarzab B; Josko J
    Neuro Endocrinol Lett; 2004; 25(1-2):141-7. PubMed ID: 15159698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.